Spyre Therapeutics logo

Spyre Therapeutics share price today

(SYRE)

Spyre Therapeutics share price is $23.86 & ₹2,027.53 as on 21 Dec 2024, 2.30 'hrs' IST

$23.86

0.73

(3.16%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Spyre Therapeutics share price in Dollar and Rupees. Guide to invest in Spyre Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Spyre Therapeutics. Get details on the Indian mutual funds that are investing in Spyre Therapeutics. Get Analyst recommendations and forecasts along with all the Spyre Therapeutics's financials.

Spyre Therapeutics share price movements

  • Today's Low: $22.75
    Today's High: $24.80

    Day's Volatility :8.26%

  • 52 Weeks Low: $16.90
    52 Weeks High: $47.97

    52 Weeks Volatility :64.77%

Spyre Therapeutics Returns

PeriodSpyre Therapeutics IncIndex (Russel 2000)
3 Months
-20.15%
0.0%
6 Months
-1.53%
0.0%
1 Year
23.63%
0.0%
3 Years
-77.33%
-19.7%

Spyre Therapeutics Key Statistics

in dollars & INR

Previous Close
$23.13
Open
$22.9
Today's High
$24.8
Today's Low
$22.7515
Market Capitalization
$1.4B
Today's Volume
$1.2M
52 Week High
$47.97
52 Week Low
$16.9
Revenue TTM
$0.0
EBITDA
$-194.5M
Earnings Per Share (EPS)
$-37.9
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-91.62%

How to invest in Spyre Therapeutics from India?

It is very easy for Indian residents to invest directly in Spyre Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Spyre Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Spyre Therapeutics or SYRE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Spyre Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Spyre Therapeutics shares which would translate to 0.036 fractional shares of Spyre Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Spyre Therapeutics, in just a few clicks!

Returns in Spyre Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Spyre Therapeutics investment value today

Current value as on today

₹1,25,823

Returns

₹25,823

(+25.82%)

Returns from Spyre Therapeutics Stock

₹23,627 (+23.63%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Spyre Therapeutics

-43%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Spyre Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -43% less investors are searching Spyre Therapeutics in the last 30 days versus the previous period.

Analyst Recommendation on Spyre Therapeutics

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Spyre Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
11
Hold
1
1
2
Sell
0
0
0

Analyst Forecast on Spyre Therapeutics

What analysts predicted

Upside of 145.7%

Current:

$23.86

Target:

$58.63

Insights on Spyre Therapeutics

  • Price Movement

    In the last 3 months, SYRE stock has moved down by -20.9%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 168.0K → 1.04M (in $), with an average increase of 40.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -38.83M → -69.02M (in $), with an average decrease of 77.7% per quarter
  • SYRE vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 99.7%

Spyre Therapeutics Technicals Summary

Sell

Neutral

Buy

Spyre Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Spyre Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Spyre Therapeutics Inc
-13.86%
-1.53%
23.63%
-77.33%
-87.95%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.38%
12.23%
86.41%
Biontech Se
4.48%
30.56%
7.97%
-55.71%
237.85%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.37%
26.29%
108.55%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-2.55%
77.79%
80.12%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Spyre Therapeutics Inc
1.72
NA
NA
-4.35
-0.92
-0.39
NA
3.34
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Spyre Therapeutics Inc
Buy
$1.4B
-87.95%
1.72
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
86.41%
17.51
33.61%
Biontech Se
Buy
$26.7B
237.85%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
108.55%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.12%
32.84
-4.51%

About Spyre Therapeutics

aeglea was founded in december of 2013 to develop engineered human enzymes invented in the laboratory of george georgiou, ph.d. of the university of texas at austin. the convergence of discovery and technology has created a significant opportunity for aeglea to impact both the treatment of inborn errors of metabolism and cancer. three drug candidates that degrade specific amino acids in the circulation are in development. for inborn errors of metabolism efforts are underway to normalize high arginine levels in patients who suffer from a gene mutation in the arginine degrading enzyme arginase1 and for patients who have mutations leading to excess levels of homocysteine. taking advantage of a cancer’s metabolic vulnerability and selectively killing only the tumor through deprivation of arginine, cysteine/cystine, and methionine are techniques in development for multiple oncology indications. coupling amino acid depletion therapy with the development of diagnostics for each oncology f
Organization
Spyre Therapeutics
Employees
30
CEO
Dr. Cameron Turtle DPHIL, Ph.D.
Industry
Miscellaneous

Management People of Spyre Therapeutics

NameTitle
Dr. Cameron Turtle DPHIL, Ph.D.
CEO & Director
Mr. Scott L. Burrows
Chief Financial Officer
Ms. Heidy Abreu King-Jones J.D., L.L.M.
Chief Legal Officer & Corporate Secretary
Dr. Janet Gunzner-Toste M.B.A., Ph.D.
Senior Vice President of Operations
Mr. Brian Connolly
Chief Technical Officer
Mr. Eric McIntyre
Vice President of Finance & Investor Relations
Mr. James Myers
Vice President of Quality & Compliance
Dr. Kelly Boothe Ph.D.
Senior Director of Corporate Communications & Investor Relations
Dr. Justin LaFountaine Ph.D.
Senior Vice President of Corporate Development
Ms. Melissa Cooper
Senior Vice President of People

Important FAQs about investing in Spyre Therapeutics from India :

What is Spyre Therapeutics share price today?

Spyre Therapeutics share price today stands at $23.86, Open: $22.90 ; Previous Close: $23.13 ; High: $24.80 ; Low: $22.75 ; 52 Week High: $47.97 ; 52 Week Low: $16.90. The stock opens at $22.90, after a previous close of $23.13. The stock reached a daily high of $24.80 and a low of $22.75, with a 52-week high of $47.97 and a 52-week low of $16.90.

Can Indians buy Spyre Therapeutics shares?

Yes, Indians can invest in the Spyre Therapeutics (SYRE) from India.

With INDmoney, you can buy Spyre Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Spyre Therapeutics at zero transaction cost.

How can I buy Spyre Therapeutics shares from India?

It is very easy to buy Spyre Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Spyre Therapeutics be purchased?

Yes, you can buy fractional shares of Spyre Therapeutics with INDmoney app.

What are the documents required to start investing in Spyre Therapeutics stocks?

To start investing in Spyre Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Spyre Therapeutics

Today’s highest price of Spyre Therapeutics (SYRE) is $24.80.

Today’s lowest price of Spyre Therapeutics (SYRE) is $22.75.

What is today's market capitalisation of Spyre Therapeutics

Today's market capitalisation of Spyre Therapeutics SYRE is 1.4B

What is the 52 Week High and Low Range of Spyre Therapeutics

  • 52 Week High

    $47.97

  • 52 Week Low

    $16.90

What are the historical returns of Spyre Therapeutics?

  • 1 Month Returns

    -13.86%

  • 3 Months Returns

    -1.53%

  • 1 Year Returns

    23.63%

  • 5 Years Returns

    -87.95%

Who is the Chief Executive Officer (CEO) of Spyre Therapeutics

Dr. Cameron Turtle DPHIL, Ph.D. is the current Chief Executive Officer (CEO) of Spyre Therapeutics.